Nuo Therapeutics, Inc. ( AURX) - Key Metrics
AURX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0.03 | -$0.01 | -$0.02 | -$0.02 |
| 2025Q4 | $0.02 | -$0.01 | -$0.01 | -$0.01 |
| 2025Q3 | $0.02 | -$0.01 | -$0.01 | -$0.01 |
| 2025Q2 | $0.01 | -$0.01 | $0.01 | $0.01 |
| 2025Q1 | $0.01 | -$0.02 | $0 | $0 |
AURX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -28.32 |
| 2025Q4 | 0% | -41.04 |
| 2025Q3 | 0% | -45.13 |
| 2025Q2 | 0% | -26.98 |
| 2025Q1 | 0% | -18.87 |
AURX
Price: $0.77
52 week price:
Earnings Per Share: -0.05 USD
P/E Ratio: -28
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 48.4 million